Home » Archive

Xconomy

News, Syndication, Xconomy »

Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks

Posted by sandiegobiotech July 15th, 2013 .
No Comments

Sometime in the coming weeks, South San Francisco-based Onyx Pharmaceuticals (NASDAQ: ONXX) will probably be acquired by some big drugmaker for more than $10 billion. Shareholders will count their…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

New Carlsbad “Germinator” Opens for Startups as DIY Biology Blooms

Posted by sandiegobiotech July 9th, 2013 .
No Comments

As an activist and founder of the Bay Area’s annual Open Science Summit, Joseph Jackson posed an intriguing question on Xconomy a few years ago: “Can a generation of “DIY” biology hobbyists help…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

The Denali Expedition: A Photo Essay

Posted by sandiegobiotech July 5th, 2013 .
No Comments

I’ve been dreaming about Denali since I started climbing mountains a decade ago with two best friends. This is the year we made it happen. As many Xconomy readers know, I just returned from a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Baseball and Biopharma: More Alike Than You Might Realize

Posted by sandiegobiotech July 3rd, 2013 .
No Comments

This may seem like a surprising observation, but it’s true. Biopharma companies and baseball teams employ similar strategies that they hope will result in either a blockbuster drug or winning the…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

MD Revolution Offers Blueprint for “Health Management” Practice

Posted by sandiegobiotech June 26th, 2013 .
No Comments

On the seventh floor of a medical office building near Scripps Memorial Hospital La Jolla, Dr. Samir Damani has established a prototype medical practice of the future. The suite looks more like a spa…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Constructing Innovation Supply Chains for the Pharmaceutical Industry

Posted by sandiegobiotech June 26th, 2013 .
No Comments

Competition via innovation has been recognized as essential for mid- to long-term success and even survival of science-based corporations such as pharmaceutical and biotechnology companies. As such,…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Aragon, Santarus, Tocagen, and More

Posted by sandiegobiotech June 20th, 2013 .
No Comments

The $1 billion buyout of San Diego’s Aragon Pharmaceuticals is expected to greatly expand Johnson & Johnson’s drug pipeline for treating prostate cancer. We have that at the top of San Diego’s…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Ernst & Young Names 2013 Entrepreneurs of the Year for San Diego

Posted by sandiegobiotech June 19th, 2013 .
No Comments

Santarus (NASDAQ: SNTS) CEO Gerald Proehl has been named as the 2013 Ernst & Young Entrepreneur of the Year for San Diego in the life sciences category, and EcoATM CEO Tom Tullie won as…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Conatus Pharmaceuticals Files for $69M IPO to Advance Liver Drugs

Posted by sandiegobiotech June 17th, 2013 .
No Comments

San Diego’s Conatus Pharmaceuticals, founded in 2005 and developing new drugs to treat chronic liver disease, plans to raise as much as $69 million through an IPO, according to a regulatory filing…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian

Posted by sandiegobiotech June 10th, 2013 .
No Comments

Biotech is a long-term business, in a world that places more value on short-term thinking. Pharma companies often cut long-term R&D budgets, or do disastrous mega-mergers, mainly to juice their…

[[Click headline to continue reading.]]

More...